FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2545662075> ?p ?o ?g. }

• W2545662075 endingPage "1832" @default.
• W2545662075 startingPage "1822" @default.
• W2545662075 abstract "Background: No reliable comparative data exist between open repair (OR) and endovascular aneurysm repair (EVAR) for mycotic abdominal aortic aneurysms (MAAAs). This nationwide study assessed outcomes after OR and EVAR for MAAA in a population-based cohort. Methods: All patients treated for MAAAs in Sweden between 1994 and 2014 were identified in the Swedish vascular registry. The primary aim was to assess survival after MAAA with OR and EVAR. Secondary aims were analyses of the rate of recurrent infections and reoperations, and time trends in surgical treatment. Survival was analyzed using Kaplan-Meier and log-rank tests. A propensity score–weighted correction for risk factor differences in the 2 groups was performed, including the operation year to account for differences in treatment and outcomes over time. Results: We identified 132 patients (0.6% of all operated abdominal aortic aneurysms in Sweden). Mean age was 70 years (standard deviation, 9.2), and 50 presented with rupture. Survival at 3 months was 86% (95% confidence interval, 80%–92%), at 1 year 79% (72%–86%), and at 5 years 59% (50%–68%). The preferred operative technique shifted from OR to EVAR after 2001 (proportion EVAR 1994–2000 0%, 2001–2007 58%, 2008–2014 60%). Open repair was performed in 62 patients (47%): aortic resection and extra-anatomic bypass (n=7), in situ reconstruction (n=50), and patch plasty (n=3); 2 patients died intraoperatively. EVAR was performed in 70 patients (53%): standard EVAR (n=55), fenestrated/branched EVAR (n=8), and visceral deviation with stent grafting (n=7); no deaths occurred intraoperatively. Survival at 3 months was lower for OR than for EVAR (74% versus 96%, P <0.001), with a similar trend present at 1 year (73% versus 84%, P =0.054). A propensity score–weighted risk-adjusted analysis confirmed the early better survival associated with EVAR. During median follow-up of 36 and 41 months for OR and EVAR, respectively, there was no difference in long-term survival (5 years 60% versus 58%, P =0.771), infection-related complications (18% versus 24%, P =0.439), or reoperation (21% versus 24%, P =0.650). Conclusion: This study demonstrates a paradigm shift in treatment of MAAA in Sweden, with EVAR being the preferred treatment modality. EVAR was associated with improved short-term survival in comparison with OR, without higher associated incidence of serious infection-related complications or reoperations." @default.
• W2545662075 created "2016-11-04" @default.
• W2545662075 creator A5012893800 @default.
• W2545662075 creator A5029419578 @default.
• W2545662075 creator A5049021473 @default.
• W2545662075 creator A5054836912 @default.
• W2545662075 creator A5071794395 @default.
• W2545662075 creator A5081161201 @default.
• W2545662075 date "2016-12-06" @default.
• W2545662075 modified "2023-10-18" @default.
• W2545662075 title "Nationwide Study of the Treatment of Mycotic Abdominal Aortic Aneurysms Comparing Open and Endovascular Repair" @default.
• W2545662075 cites W1255227546 @default.
• W2545662075 cites W1966471173 @default.
• W2545662075 cites W1973424996 @default.
• W2545662075 cites W1987154468 @default.
• W2545662075 cites W2006118342 @default.
• W2545662075 cites W2011652716 @default.
• W2545662075 cites W2018446794 @default.
• W2545662075 cites W2020428556 @default.
• W2545662075 cites W2024080811 @default.
• W2545662075 cites W2025904534 @default.
• W2545662075 cites W2026542485 @default.
• W2545662075 cites W2036056356 @default.
• W2545662075 cites W2050891440 @default.
• W2545662075 cites W2059867576 @default.
• W2545662075 cites W2060187645 @default.
• W2545662075 cites W2060778166 @default.
• W2545662075 cites W2065067499 @default.
• W2545662075 cites W2075868598 @default.
• W2545662075 cites W2088936274 @default.
• W2545662075 cites W2093858187 @default.
• W2545662075 cites W2094966899 @default.
• W2545662075 cites W2101552752 @default.
• W2545662075 cites W2104638802 @default.
• W2545662075 cites W2106839193 @default.
• W2545662075 cites W2123871403 @default.
• W2545662075 cites W2134556758 @default.
• W2545662075 cites W2157281193 @default.
• W2545662075 cites W2170584445 @default.
• W2545662075 doi "https://doi.org/10.1161/circulationaha.116.024021" @default.
• W2545662075 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27799273" @default.
• W2545662075 hasPublicationYear "2016" @default.
• W2545662075 type Work @default.
• W2545662075 sameAs 2545662075 @default.
• W2545662075 citedByCount "146" @default.
• W2545662075 countsByYear W25456620752017 @default.
• W2545662075 countsByYear W25456620752018 @default.
• W2545662075 countsByYear W25456620752019 @default.
• W2545662075 countsByYear W25456620752020 @default.
• W2545662075 countsByYear W25456620752021 @default.
• W2545662075 countsByYear W25456620752022 @default.
• W2545662075 countsByYear W25456620752023 @default.
• W2545662075 crossrefType "journal-article" @default.
• W2545662075 hasAuthorship W2545662075A5012893800 @default.
• W2545662075 hasAuthorship W2545662075A5029419578 @default.
• W2545662075 hasAuthorship W2545662075A5049021473 @default.
• W2545662075 hasAuthorship W2545662075A5054836912 @default.
• W2545662075 hasAuthorship W2545662075A5071794395 @default.
• W2545662075 hasAuthorship W2545662075A5081161201 @default.
• W2545662075 hasBestOaLocation W25456620751 @default.
• W2545662075 hasConcept C126322002 @default.
• W2545662075 hasConcept C126838900 @default.
• W2545662075 hasConcept C141071460 @default.
• W2545662075 hasConcept C17923572 @default.
• W2545662075 hasConcept C2776098176 @default.
• W2545662075 hasConcept C2776283816 @default.
• W2545662075 hasConcept C2776543907 @default.
• W2545662075 hasConcept C2777323849 @default.
• W2545662075 hasConcept C2779993416 @default.
• W2545662075 hasConcept C2908647359 @default.
• W2545662075 hasConcept C44249647 @default.
• W2545662075 hasConcept C71924100 @default.
• W2545662075 hasConcept C72563966 @default.
• W2545662075 hasConcept C99454951 @default.
• W2545662075 hasConceptScore W2545662075C126322002 @default.
• W2545662075 hasConceptScore W2545662075C126838900 @default.
• W2545662075 hasConceptScore W2545662075C141071460 @default.
• W2545662075 hasConceptScore W2545662075C17923572 @default.
• W2545662075 hasConceptScore W2545662075C2776098176 @default.
• W2545662075 hasConceptScore W2545662075C2776283816 @default.
• W2545662075 hasConceptScore W2545662075C2776543907 @default.
• W2545662075 hasConceptScore W2545662075C2777323849 @default.
• W2545662075 hasConceptScore W2545662075C2779993416 @default.
• W2545662075 hasConceptScore W2545662075C2908647359 @default.
• W2545662075 hasConceptScore W2545662075C44249647 @default.
• W2545662075 hasConceptScore W2545662075C71924100 @default.
• W2545662075 hasConceptScore W2545662075C72563966 @default.
• W2545662075 hasConceptScore W2545662075C99454951 @default.
• W2545662075 hasIssue "23" @default.
• W2545662075 hasLocation W25456620751 @default.
• W2545662075 hasLocation W25456620752 @default.
• W2545662075 hasOpenAccess W2545662075 @default.
• W2545662075 hasPrimaryLocation W25456620751 @default.
• W2545662075 hasRelatedWork W1963977372 @default.
• W2545662075 hasRelatedWork W1968731988 @default.
• W2545662075 hasRelatedWork W2107952077 @default.
• W2545662075 hasRelatedWork W2118424145 @default.
• W2545662075 hasRelatedWork W2278106922 @default.

• next